Cite
Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies
MLA
Y.C. Mayur, et al. “Acridone-Pyrimidine Hybrids- Design, Synthesis, Cytotoxicity Studies in Resistant and Sensitive Cancer Cells and Molecular Docking Studies.” European Journal of Medicinal Chemistry, vol. 139, Jan. 2017, pp. 961–81. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9494a52abe06d7a2db9e91970adb656b&authtype=sso&custid=ns315887.
APA
Y.C. Mayur, Godefridus J. Peters, Manikanta Murahari, & Karanam Vanitha Prakash. (2017). Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies. European Journal of Medicinal Chemistry, 139, 961–981.
Chicago
Y.C. Mayur, Godefridus J. Peters, Manikanta Murahari, and Karanam Vanitha Prakash. 2017. “Acridone-Pyrimidine Hybrids- Design, Synthesis, Cytotoxicity Studies in Resistant and Sensitive Cancer Cells and Molecular Docking Studies.” European Journal of Medicinal Chemistry 139 (January): 961–81. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9494a52abe06d7a2db9e91970adb656b&authtype=sso&custid=ns315887.